0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Needle-Free Injection Device Market Research Report 2026
Published Date: 2026-04-17
|
Report Code: QYRE-Auto-9S17080
Home | Market Reports
Global Insulin Needle Free Injection Device Market Research Report 2024
BUY CHAPTERS

Global Insulin Needle-Free Injection Device Market Research Report 2026

Code: QYRE-Auto-9S17080
Report
2026-04-17
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Insulin Needle-Free Injection Device Market

The global Insulin Needle-Free Injection Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Insulin Needle-Free Injection Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An insulin needleless injection device is a medical device used to administer insulin therapy that allows patients to inject insulin through the surface of the skin without using a traditional injection needle. This device usually uses a special technology, such as a high-pressure gas or high-speed liquid jet, to spray a dose of insulin onto the surface of the skin, where it is then absorbed through the skin into the bloodstream.
The North American market for Insulin Needle-Free Injection Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Insulin Needle-Free Injection Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Insulin Needle-Free Injection Device include 3M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Insulin Needle-Free Injection Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Insulin Needle-Free Injection Device. The Insulin Needle-Free Injection Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Insulin Needle-Free Injection Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Insulin Needle-Free Injection Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Insulin Needle-Free Injection Device Market Report

Report Metric Details
Report Name Insulin Needle-Free Injection Device Market
Segment by Type
  • Compressed
  • Liquid Jet
by Application
  • Hospital
  • Clinic
  • Rehabilitation Center
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company 3M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, Zogenix, Advantajet, InsuJet, Antares Pharma, D'Antonio Consultants International, PenJet Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Insulin Needle-Free Injection Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Insulin Needle-Free Injection Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Insulin Needle-Free Injection Device Market report?

Ans: The main players in the Insulin Needle-Free Injection Device Market are 3M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, Zogenix, Advantajet, InsuJet, Antares Pharma, D'Antonio Consultants International, PenJet Corporation

What are the Application segmentation covered in the Insulin Needle-Free Injection Device Market report?

Ans: The Applications covered in the Insulin Needle-Free Injection Device Market report are Hospital, Clinic, Rehabilitation Center, Others

What are the Type segmentation covered in the Insulin Needle-Free Injection Device Market report?

Ans: The Types covered in the Insulin Needle-Free Injection Device Market report are Compressed, Liquid Jet

1 Insulin Needle-Free Injection Device Market Overview
1.1 Product Definition
1.2 Insulin Needle-Free Injection Device by Type
1.2.1 Global Insulin Needle-Free Injection Device Market Value by Type: 2025 vs 2032
1.2.2 Compressed
1.2.3 Liquid Jet
1.3 Insulin Needle-Free Injection Device by Application
1.3.1 Global Insulin Needle-Free Injection Device Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Rehabilitation Center
1.3.5 Others
1.4 Global Insulin Needle-Free Injection Device Market Size Estimates and Forecasts
1.4.1 Global Insulin Needle-Free Injection Device Revenue 2021–2032
1.4.2 Global Insulin Needle-Free Injection Device Sales 2021–2032
1.4.3 Global Insulin Needle-Free Injection Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Insulin Needle-Free Injection Device Market Competition by Manufacturers
2.1 Global Insulin Needle-Free Injection Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Insulin Needle-Free Injection Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Insulin Needle-Free Injection Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Insulin Needle-Free Injection Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Insulin Needle-Free Injection Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Insulin Needle-Free Injection Device, Product Types and Applications
2.7 Global Key Manufacturers of Insulin Needle-Free Injection Device, Date of Entry into the Industry
2.8 Global Insulin Needle-Free Injection Device Market Competitive Situation and Trends
2.8.1 Global Insulin Needle-Free Injection Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Insulin Needle-Free Injection Device Players Market Share by Revenue
2.8.3 Global Insulin Needle-Free Injection Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Needle-Free Injection Device Market Scenario by Region
3.1 Global Insulin Needle-Free Injection Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Insulin Needle-Free Injection Device Sales by Region: 2021–2032
3.2.1 Global Insulin Needle-Free Injection Device Sales by Region: 2021–2026
3.2.2 Global Insulin Needle-Free Injection Device Sales by Region: 2027–2032
3.3 Global Insulin Needle-Free Injection Device Revenue by Region: 2021–2032
3.3.1 Global Insulin Needle-Free Injection Device Revenue by Region: 2021–2026
3.3.2 Global Insulin Needle-Free Injection Device Revenue by Region: 2027–2032
3.4 North America Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.4.1 North America Insulin Needle-Free Injection Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Insulin Needle-Free Injection Device Sales by Country (2021–2032)
3.4.3 North America Insulin Needle-Free Injection Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.5.1 Europe Insulin Needle-Free Injection Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Insulin Needle-Free Injection Device Sales by Country (2021–2032)
3.5.3 Europe Insulin Needle-Free Injection Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Needle-Free Injection Device Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Needle-Free Injection Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Insulin Needle-Free Injection Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Insulin Needle-Free Injection Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.7.1 Latin America Insulin Needle-Free Injection Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Insulin Needle-Free Injection Device Sales by Country (2021–2032)
3.7.3 Latin America Insulin Needle-Free Injection Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Needle-Free Injection Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Insulin Needle-Free Injection Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Needle-Free Injection Device Sales by Type (2021–2032)
4.1.1 Global Insulin Needle-Free Injection Device Sales by Type (2021–2026)
4.1.2 Global Insulin Needle-Free Injection Device Sales by Type (2027–2032)
4.1.3 Global Insulin Needle-Free Injection Device Sales Market Share by Type (2021–2032)
4.2 Global Insulin Needle-Free Injection Device Revenue by Type (2021–2032)
4.2.1 Global Insulin Needle-Free Injection Device Revenue by Type (2021–2026)
4.2.2 Global Insulin Needle-Free Injection Device Revenue by Type (2027–2032)
4.2.3 Global Insulin Needle-Free Injection Device Revenue Market Share by Type (2021–2032)
4.3 Global Insulin Needle-Free Injection Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Insulin Needle-Free Injection Device Sales by Application (2021–2032)
5.1.1 Global Insulin Needle-Free Injection Device Sales by Application (2021–2026)
5.1.2 Global Insulin Needle-Free Injection Device Sales by Application (2027–2032)
5.1.3 Global Insulin Needle-Free Injection Device Sales Market Share by Application (2021–2032)
5.2 Global Insulin Needle-Free Injection Device Revenue by Application (2021–2032)
5.2.1 Global Insulin Needle-Free Injection Device Revenue by Application (2021–2026)
5.2.2 Global Insulin Needle-Free Injection Device Revenue by Application (2027–2032)
5.2.3 Global Insulin Needle-Free Injection Device Revenue Market Share by Application (2021–2032)
5.3 Global Insulin Needle-Free Injection Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Company Information
6.1.2 3M Description and Business Overview
6.1.3 3M Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 3M Insulin Needle-Free Injection Device Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Bioject Medical Technologies
6.2.1 Bioject Medical Technologies Company Information
6.2.2 Bioject Medical Technologies Description and Business Overview
6.2.3 Bioject Medical Technologies Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bioject Medical Technologies Insulin Needle-Free Injection Device Product Portfolio
6.2.5 Bioject Medical Technologies Recent Developments/Updates
6.3 Eternity Healthcare
6.3.1 Eternity Healthcare Company Information
6.3.2 Eternity Healthcare Description and Business Overview
6.3.3 Eternity Healthcare Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eternity Healthcare Insulin Needle-Free Injection Device Product Portfolio
6.3.5 Eternity Healthcare Recent Developments/Updates
6.4 Crossject
6.4.1 Crossject Company Information
6.4.2 Crossject Description and Business Overview
6.4.3 Crossject Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Crossject Insulin Needle-Free Injection Device Product Portfolio
6.4.5 Crossject Recent Developments/Updates
6.5 National Medical Products
6.5.1 National Medical Products Company Information
6.5.2 National Medical Products Description and Business Overview
6.5.3 National Medical Products Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 National Medical Products Insulin Needle-Free Injection Device Product Portfolio
6.5.5 National Medical Products Recent Developments/Updates
6.6 Valeritas
6.6.1 Valeritas Company Information
6.6.2 Valeritas Description and Business Overview
6.6.3 Valeritas Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Valeritas Insulin Needle-Free Injection Device Product Portfolio
6.6.5 Valeritas Recent Developments/Updates
6.7 Neo Laboratories
6.7.1 Neo Laboratories Company Information
6.7.2 Neo Laboratories Description and Business Overview
6.7.3 Neo Laboratories Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Neo Laboratories Insulin Needle-Free Injection Device Product Portfolio
6.7.5 Neo Laboratories Recent Developments/Updates
6.8 PharmaJet
6.8.1 PharmaJet Company Information
6.8.2 PharmaJet Description and Business Overview
6.8.3 PharmaJet Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 PharmaJet Insulin Needle-Free Injection Device Product Portfolio
6.8.5 PharmaJet Recent Developments/Updates
6.9 Medical International Technology
6.9.1 Medical International Technology Company Information
6.9.2 Medical International Technology Description and Business Overview
6.9.3 Medical International Technology Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Medical International Technology Insulin Needle-Free Injection Device Product Portfolio
6.9.5 Medical International Technology Recent Developments/Updates
6.10 Bespak
6.10.1 Bespak Company Information
6.10.2 Bespak Description and Business Overview
6.10.3 Bespak Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bespak Insulin Needle-Free Injection Device Product Portfolio
6.10.5 Bespak Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Company Information
6.11.2 Zogenix Description and Business Overview
6.11.3 Zogenix Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zogenix Insulin Needle-Free Injection Device Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
6.12 Advantajet
6.12.1 Advantajet Company Information
6.12.2 Advantajet Description and Business Overview
6.12.3 Advantajet Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Advantajet Insulin Needle-Free Injection Device Product Portfolio
6.12.5 Advantajet Recent Developments/Updates
6.13 InsuJet
6.13.1 InsuJet Company Information
6.13.2 InsuJet Description and Business Overview
6.13.3 InsuJet Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 InsuJet Insulin Needle-Free Injection Device Product Portfolio
6.13.5 InsuJet Recent Developments/Updates
6.14 Antares Pharma
6.14.1 Antares Pharma Company Information
6.14.2 Antares Pharma Description and Business Overview
6.14.3 Antares Pharma Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Antares Pharma Insulin Needle-Free Injection Device Product Portfolio
6.14.5 Antares Pharma Recent Developments/Updates
6.15 D'Antonio Consultants International
6.15.1 D'Antonio Consultants International Company Information
6.15.2 D'Antonio Consultants International Description and Business Overview
6.15.3 D'Antonio Consultants International Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 D'Antonio Consultants International Insulin Needle-Free Injection Device Product Portfolio
6.15.5 D'Antonio Consultants International Recent Developments/Updates
6.16 PenJet Corporation
6.16.1 PenJet Corporation Company Information
6.16.2 PenJet Corporation Description and Business Overview
6.16.3 PenJet Corporation Insulin Needle-Free Injection Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 PenJet Corporation Insulin Needle-Free Injection Device Product Portfolio
6.16.5 PenJet Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Needle-Free Injection Device Industry Chain Analysis
7.2 Insulin Needle-Free Injection Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Needle-Free Injection Device Production Mode & Process Analysis
7.4 Insulin Needle-Free Injection Device Sales and Marketing
7.4.1 Insulin Needle-Free Injection Device Sales Channels
7.4.2 Insulin Needle-Free Injection Device Distributors
7.5 Insulin Needle-Free Injection Device Customer Analysis
8 Insulin Needle-Free Injection Device Market Dynamics
8.1 Insulin Needle-Free Injection Device Industry Trends
8.2 Insulin Needle-Free Injection Device Market Drivers
8.3 Insulin Needle-Free Injection Device Market Challenges
8.4 Insulin Needle-Free Injection Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Insulin Needle-Free Injection Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Insulin Needle-Free Injection Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Insulin Needle-Free Injection Device Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Insulin Needle-Free Injection Device Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Insulin Needle-Free Injection Device Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Insulin Needle-Free Injection Device Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Insulin Needle-Free Injection Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Insulin Needle-Free Injection Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Insulin Needle-Free Injection Device, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Insulin Needle-Free Injection Device, Product Types and Applications
 Table 12. Global Key Manufacturers of Insulin Needle-Free Injection Device, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Insulin Needle-Free Injection Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Insulin Needle-Free Injection Device Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Insulin Needle-Free Injection Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Insulin Needle-Free Injection Device Sales by Region (Units), 2021–2026
 Table 18. Global Insulin Needle-Free Injection Device Sales Market Share by Region (2021–2026)
 Table 19. Global Insulin Needle-Free Injection Device Sales by Region (Units), 2027–2032
 Table 20. Global Insulin Needle-Free Injection Device Sales Market Share by Region (2027–2032)
 Table 21. Global Insulin Needle-Free Injection Device Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Insulin Needle-Free Injection Device Revenue Market Share by Region (2021–2026)
 Table 23. Global Insulin Needle-Free Injection Device Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Insulin Needle-Free Injection Device Revenue Market Share by Region (2027–2032)
 Table 25. North America Insulin Needle-Free Injection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Insulin Needle-Free Injection Device Sales by Country (Units), 2021–2026
 Table 27. North America Insulin Needle-Free Injection Device Sales by Country (Units), 2027–2032
 Table 28. North America Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Insulin Needle-Free Injection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Insulin Needle-Free Injection Device Sales by Country (Units), 2021–2026
 Table 32. Europe Insulin Needle-Free Injection Device Sales by Country (Units), 2027–2032
 Table 33. Europe Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Insulin Needle-Free Injection Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Insulin Needle-Free Injection Device Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Insulin Needle-Free Injection Device Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Insulin Needle-Free Injection Device Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Insulin Needle-Free Injection Device Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Insulin Needle-Free Injection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Insulin Needle-Free Injection Device Sales by Country (Units), 2021–2026
 Table 42. Latin America Insulin Needle-Free Injection Device Sales by Country (Units), 2027–2032
 Table 43. Latin America Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Insulin Needle-Free Injection Device Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Insulin Needle-Free Injection Device Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Insulin Needle-Free Injection Device Sales (Units) by Type (2021–2026)
 Table 51. Global Insulin Needle-Free Injection Device Sales (Units) by Type (2027–2032)
 Table 52. Global Insulin Needle-Free Injection Device Sales Market Share by Type (2021–2026)
 Table 53. Global Insulin Needle-Free Injection Device Sales Market Share by Type (2027–2032)
 Table 54. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Insulin Needle-Free Injection Device Revenue Market Share by Type (2021–2026)
 Table 57. Global Insulin Needle-Free Injection Device Revenue Market Share by Type (2027–2032)
 Table 58. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Insulin Needle-Free Injection Device Sales (Units) by Application (2021–2026)
 Table 61. Global Insulin Needle-Free Injection Device Sales (Units) by Application (2027–2032)
 Table 62. Global Insulin Needle-Free Injection Device Sales Market Share by Application (2021–2026)
 Table 63. Global Insulin Needle-Free Injection Device Sales Market Share by Application (2027–2032)
 Table 64. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Insulin Needle-Free Injection Device Revenue Market Share by Application (2021–2026)
 Table 67. Global Insulin Needle-Free Injection Device Revenue Market Share by Application (2027–2032)
 Table 68. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Application (2027–2032)
 Table 70. 3M Company Information
 Table 71. 3M Description and Business Overview
 Table 72. 3M Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. 3M Insulin Needle-Free Injection Device Product
 Table 74. 3M Recent Developments/Updates
 Table 75. Bioject Medical Technologies Company Information
 Table 76. Bioject Medical Technologies Description and Business Overview
 Table 77. Bioject Medical Technologies Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Bioject Medical Technologies Insulin Needle-Free Injection Device Product
 Table 79. Bioject Medical Technologies Recent Developments/Updates
 Table 80. Eternity Healthcare Company Information
 Table 81. Eternity Healthcare Description and Business Overview
 Table 82. Eternity Healthcare Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Eternity Healthcare Insulin Needle-Free Injection Device Product
 Table 84. Eternity Healthcare Recent Developments/Updates
 Table 85. Crossject Company Information
 Table 86. Crossject Description and Business Overview
 Table 87. Crossject Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Crossject Insulin Needle-Free Injection Device Product
 Table 89. Crossject Recent Developments/Updates
 Table 90. National Medical Products Company Information
 Table 91. National Medical Products Description and Business Overview
 Table 92. National Medical Products Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. National Medical Products Insulin Needle-Free Injection Device Product
 Table 94. National Medical Products Recent Developments/Updates
 Table 95. Valeritas Company Information
 Table 96. Valeritas Description and Business Overview
 Table 97. Valeritas Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Valeritas Insulin Needle-Free Injection Device Product
 Table 99. Valeritas Recent Developments/Updates
 Table 100. Neo Laboratories Company Information
 Table 101. Neo Laboratories Description and Business Overview
 Table 102. Neo Laboratories Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Neo Laboratories Insulin Needle-Free Injection Device Product
 Table 104. Neo Laboratories Recent Developments/Updates
 Table 105. PharmaJet Company Information
 Table 106. PharmaJet Description and Business Overview
 Table 107. PharmaJet Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. PharmaJet Insulin Needle-Free Injection Device Product
 Table 109. PharmaJet Recent Developments/Updates
 Table 110. Medical International Technology Company Information
 Table 111. Medical International Technology Description and Business Overview
 Table 112. Medical International Technology Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Medical International Technology Insulin Needle-Free Injection Device Product
 Table 114. Medical International Technology Recent Developments/Updates
 Table 115. Bespak Company Information
 Table 116. Bespak Description and Business Overview
 Table 117. Bespak Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Bespak Insulin Needle-Free Injection Device Product
 Table 119. Bespak Recent Developments/Updates
 Table 120. Zogenix Company Information
 Table 121. Zogenix Description and Business Overview
 Table 122. Zogenix Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Zogenix Insulin Needle-Free Injection Device Product
 Table 124. Zogenix Recent Developments/Updates
 Table 125. Advantajet Company Information
 Table 126. Advantajet Description and Business Overview
 Table 127. Advantajet Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Advantajet Insulin Needle-Free Injection Device Product
 Table 129. Advantajet Recent Developments/Updates
 Table 130. InsuJet Company Information
 Table 131. InsuJet Description and Business Overview
 Table 132. InsuJet Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. InsuJet Insulin Needle-Free Injection Device Product
 Table 134. InsuJet Recent Developments/Updates
 Table 135. Antares Pharma Company Information
 Table 136. Antares Pharma Description and Business Overview
 Table 137. Antares Pharma Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Antares Pharma Insulin Needle-Free Injection Device Product
 Table 139. Antares Pharma Recent Developments/Updates
 Table 140. D'Antonio Consultants International Company Information
 Table 141. D'Antonio Consultants International Description and Business Overview
 Table 142. D'Antonio Consultants International Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. D'Antonio Consultants International Insulin Needle-Free Injection Device Product
 Table 144. D'Antonio Consultants International Recent Developments/Updates
 Table 145. PenJet Corporation Company Information
 Table 146. PenJet Corporation Description and Business Overview
 Table 147. PenJet Corporation Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. PenJet Corporation Insulin Needle-Free Injection Device Product
 Table 149. PenJet Corporation Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Insulin Needle-Free Injection Device Distributors List
 Table 153. Insulin Needle-Free Injection Device Customers List
 Table 154. Insulin Needle-Free Injection Device Market Trends
 Table 155. Insulin Needle-Free Injection Device Market Drivers
 Table 156. Insulin Needle-Free Injection Device Market Challenges
 Table 157. Insulin Needle-Free Injection Device Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Insulin Needle-Free Injection Device
 Figure 2. Global Insulin Needle-Free Injection Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Insulin Needle-Free Injection Device Market Share by Type: 2025 & 2032
 Figure 4. Compressed Product Picture
 Figure 5. Liquid Jet Product Picture
 Figure 6. Global Insulin Needle-Free Injection Device Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Insulin Needle-Free Injection Device Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Rehabilitation Center
 Figure 11. Others
 Figure 12. Global Insulin Needle-Free Injection Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Insulin Needle-Free Injection Device Market Size (US$ Million), 2021–2032
 Figure 14. Global Insulin Needle-Free Injection Device Sales (Units), 2021–2032
 Figure 15. Global Insulin Needle-Free Injection Device Average Price (US$/Unit), 2021–2032
 Figure 16. Insulin Needle-Free Injection Device Report Years Considered
 Figure 17. Insulin Needle-Free Injection Device Sales Share by Manufacturers in 2025
 Figure 18. Global Insulin Needle-Free Injection Device Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Insulin Needle-Free Injection Device Players: Market Share by Revenue in Insulin Needle-Free Injection Device in 2025
 Figure 20. Insulin Needle-Free Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Insulin Needle-Free Injection Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Insulin Needle-Free Injection Device Sales Market Share by Country (2021–2032)
 Figure 23. North America Insulin Needle-Free Injection Device Revenue Market Share by Country (2021–2032)
 Figure 24. United States Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Insulin Needle-Free Injection Device Sales Market Share by Country (2021–2032)
 Figure 27. Europe Insulin Needle-Free Injection Device Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Insulin Needle-Free Injection Device Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Insulin Needle-Free Injection Device Revenue Market Share by Region (2021–2032)
 Figure 35. China Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Insulin Needle-Free Injection Device Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Insulin Needle-Free Injection Device Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Insulin Needle-Free Injection Device Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Insulin Needle-Free Injection Device Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Insulin Needle-Free Injection Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Insulin Needle-Free Injection Device by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Insulin Needle-Free Injection Device by Type (2021–2032)
 Figure 55. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Insulin Needle-Free Injection Device by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Insulin Needle-Free Injection Device by Application (2021–2032)
 Figure 58. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Application (2021–2032)
 Figure 59. Insulin Needle-Free Injection Device Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension